No results for ‘’
3B Blackbio DX Ltd
₹1419.90
(1.62%)
Sun, 13 Sept 2026, 09:18 am
Process Industries
Chemicals: Agricultural
24.5K3B Blackbio DX Ratios
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 21.59 | 10.95 | 19.19 | 0 | 12.94 | 12.45 | 22.92 | 15.19 | 19.49 | 24.89 | 9.21 | 7.07 | 1.87 | 7.94 | 12.01 | 20.54 | 29.05 |
| Price to book ratio | 0 | 0.77 | 0.70 | 1.87 | 0.97 | 0.54 | 0.48 | 0.52 | 0.48 | 1.98 | 4.68 | 2.15 | 1.70 | 1.62 | 1.67 | 1.82 | 2.96 | 5.17 |
| Price to sales ratio | 0 | 0.38 | 0.30 | 0.73 | 0.43 | 0.26 | 0.22 | 0.28 | 0.29 | 1.36 | 3.68 | 2.07 | 1.88 | 0.94 | 3.17 | 5.04 | 8.90 | 14.36 |
| Price to cash flow ratio | 0 | 38.44 | 3.27 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 70.56 | 15.53 | 8.10 | 2.19 | 5.70 | 12.48 | 24.58 | 32.03 |
| Enterprise value | 0 | 8.55Cr | 7.56Cr | 18.12Cr | 13.08Cr | 10.69Cr | 11.12Cr | 12.31Cr | 12.27Cr | 30.31Cr | 89.67Cr | 51.32Cr | 50.63Cr | 196Cr | 248Cr | 279Cr | 601Cr | 1319Cr |
| Enterprise value to EBITDA ratio | 0 | 8.58 | 6.27 | 10.29 | 12.20 | 8.16 | 8.49 | 9.16 | 8.14 | 10.70 | 16.52 | 7.11 | 5.43 | 1.31 | 6.69 | 9.57 | 18.21 | 26.17 |
| Debt to equity ratio | 0 | 0.43 | 0.34 | 0.42 | 0.61 | 0.62 | 0.69 | 0.74 | 0.74 | 0.78 | 0.32 | 0.27 | 0.11 | 0.02 | 0.02 | 0.01 | 0 | 0 |
| Return on equity % | 0 | 0 | 6.60 | 9.68 | -0.14 | 4.28 | 3.86 | 2.31 | 3.25 | 10.48 | 23.26 | 25.67 | 28.13 | 138.70 | 22.59 | 16 | 16.28 | 19.41 |
3B Blackbio DX Ltd Ratios
The 3B Blackbio DX Ltd Ratios page provides a complete fundamental analysis of 3B Blackbio DX Ltd using key valuation, profitability, and financial strength metrics. Investors tracking 3B Blackbio DX Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
3B Blackbio DX Ltd (NSE: , BSE: 532067) is currently trading at ₹1419.90, with a market capitalization of ₹1241.4Cr. As a major player in the Process industries sector and Chemicals: agricultural industry, 3B Blackbio DX Ltd remains a key stock for fundamental analysis using 3B Blackbio DX Ltd Ratios.
3B Blackbio DX Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The 3B Blackbio DX Ltd P/E ratio currently stands at 29.05, making it one of the most tracked metrics in 3B Blackbio DX Ltd Ratios.
Historically, the 3B Blackbio DX Ltd P/E ratio has shown strong fluctuations:
- 2024: 29.05
- 2023: 20.54
- 2022: 12.01
- 2021: 7.94
- 2020: 1.87
The rising 3B Blackbio DX Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The 3B Blackbio DX Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.17.
Historical P/B trend:
- 2024: 5.17
- 2023: 2.96
- 2022: 1.82
- 2021: 1.67
3B Blackbio DX Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The 3B Blackbio DX Ltd P/S ratio currently stands at 14.36, an important part of 3B Blackbio DX Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 14.36
- 2023: 8.90
- 2022: 5.04
- 2021: 3.17
The rising 3B Blackbio DX Ltd P/S ratio indicates improved revenue valuation by investors.
3B Blackbio DX Ltd Price to Cash Flow Ratio (P/CF)
The 3B Blackbio DX Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 32.03.
Historical 3B Blackbio DX Ltd Price to Cash Flow Ratio:
- 2024: 32.03
- 2023: 24.58
- 2022: 12.48
- 2021: 5.70
- 2020: 2.19
The rising 3B Blackbio DX Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
3B Blackbio DX Ltd Enterprise Value Ratios
Enterprise Value (EV)
The 3B Blackbio DX Ltd EV currently stands at ₹1319Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 1319Cr
- 2023: 601Cr
- 2022: 279Cr
- 2021: 248Cr
3B Blackbio DX Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The 3B Blackbio DX Ltd EV/EBITDA ratio is currently 26.17, a key metric in 3B Blackbio DX Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 26.17
- 2023: 18.21
- 2022: 9.57
- 2021: 6.69
Higher 3B Blackbio DX Ltd EV/EBITDA suggests premium valuation.
3B Blackbio DX Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The 3B Blackbio DX Ltd D/E ratio is currently 0, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0
- 2023: 0
- 2022: 0.01
- 2021: 0.02
3B Blackbio DX Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The 3B Blackbio DX Ltd ROE currently stands at 19.41%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 19.41
- 2023: 16.28
- 2022: 16
- 2021: 22.59
3B Blackbio DX Ltd maintains stable profitability levels.
3B Blackbio DX Ltd Ratios Analysis Summary
The 3B Blackbio DX Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether 3B Blackbio DX Ltd stock is undervalued, fairly valued, or overvalued.
Tracking 3B Blackbio DX Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.